CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-02 | Drake Neil VP Research and Development | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-08-23 | Drake Neil VP Research and Development | Grant or award | +13,736 | $1.82 | $25K | 61,267 |
| 2018-05-15 | Drake Neil VP Research and Development | Grant or award | +17,938 | 17,938 | ||
| 2018-04-30 | Drake Neil VP Research and Development | Grant or award | +2,743 | $3.27 | $9K | 29,593 |
| 2018-03-15 | Drake Neil VP Research and Development | Purchase | +5,000 | $3.96 | $20K | 26,850 |
| 2018-02-02 | Drake Neil VP Research and Development | Option exercise | +229 | $1.31 | $300 | 8,153 |
| 2018-02-02 | Drake Neil VP Research and Development | Option exercise | +5,746 | $1.83 | $11K | 13,899 |
| 2018-02-02 | Drake Neil VP Research and Development | Option exercise | +3,641 | $0.76 | $3K | 17,540 |
| 2018-02-02 | Drake Neil VP Research and Development | Option exercise | +4,310 | $1.77 | $8K | 21,850 |
| 2018-02-02 | Drake Neil VP Research and Development | Option exercise · Employee Stock Option (right to buy) | −229 | 0 | ||
| 2018-02-02 | Drake Neil VP Research and Development | Option exercise · Employee Stock Option (right to buy) | −5,746 | 0 | ||
| 2018-02-02 | Drake Neil VP Research and Development | Option exercise · Employee Stock Option (right to buy) | −3,641 | 1,083 | ||
| 2018-02-02 | Drake Neil VP Research and Development | Option exercise · Employee Stock Option (right to buy) | −4,310 | 6,034 | ||
| 2018-01-02 | Drake Neil VP Research and Development | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2017-10-31 | Drake Neil VP Research and Development | Grant or award | +1,743 | $7.17 | $12K | 7,924 |
| 2017-04-30 | Drake Neil Director | Grant or award | +1,661 | $9.03 | $15K | 6,181 |
Page 1 of 1 · 16 trades